Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception

Background: Informed consent in clinical research is mandated throughout the world. Both patient subjects and investigators are required to understand and accept the distinction between research and treatment.Aim: To document the extent and to identify factors associated with therapeutic misconcepti...

Full description

Saved in:  
Bibliographic Details
Authors: Durand-Zaleski, I. S. (Author) ; Alberti, C. (Author) ; Durieux, P. (Author) ; Duval, X. (Author) ; Gottot, S. (Author) ; Ravaud, Ph (Author) ; Gainotti, S. (Author) ; Vincent-Genod, C. (Author) ; Moreau, D. (Author) ; Amiel, P. (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2008
In: Journal of medical ethics
Year: 2008, Volume: 34, Issue: 9, Pages: 16
Online Access: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002 4500
001 1816135666
003 DE-627
005 20220908053456.0
007 cr uuu---uuuuu
008 220908s2008 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.2007.023473  |2 doi 
035 |a (DE-627)1816135666 
035 |a (DE-599)KXP1816135666 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Durand-Zaleski, I. S.  |e VerfasserIn  |4 aut 
245 1 0 |a Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception 
264 1 |c 2008 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Background: Informed consent in clinical research is mandated throughout the world. Both patient subjects and investigators are required to understand and accept the distinction between research and treatment.Aim: To document the extent and to identify factors associated with therapeutic misconception in a population of patient subjects or parent proxies recruited from a variety of multicentre trials (parent studies).Patients and methods: The study comprised two phases: the development of a questionnaire to assess the quality of informed consent and a survey of patient subjects based on this questionnaire.Results: A total of 303 patient subjects or parent proxies were contacted and 279 questionnaires were analysed. The median age was 49.5 years, sex ratio was 1 and 61% of respondents were professionally active. Overall memorisation of the oral or written communication of informed consent was good (69-97%), and satisfaction with the process was around 70%. Therapeutic misconception was present in 70% of respondents, who expected to receive better care and ignored the consequence of randomisation and treatment comparisons. This was positively associated with the acuteness and severity of the disease.Conclusion: The authors suggest that the risk of therapeutic misconception be specifically addressed in consent forms as an educational tool for both patients and investigators. 
601 |a Therapeut 
700 1 |a Alberti, C.  |e VerfasserIn  |4 aut 
700 1 |a Durieux, P.  |e VerfasserIn  |4 aut 
700 1 |a Duval, X.  |e VerfasserIn  |4 aut 
700 1 |a Gottot, S.  |e VerfasserIn  |4 aut 
700 1 |a Ravaud, Ph  |e VerfasserIn  |4 aut 
700 1 |a Gainotti, S.  |e VerfasserIn  |4 aut 
700 1 |a Vincent-Genod, C.  |e VerfasserIn  |4 aut 
700 1 |a Moreau, D.  |e VerfasserIn  |4 aut 
700 1 |a Amiel, P.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 34(2008), 9, Seite 16  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:34  |g year:2008  |g number:9  |g pages:16 
856 4 0 |u https://doi.org/10.1136/jme.2007.023473  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/34/9/e16.abstract  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185589530 
LOK |0 003 DE-627 
LOK |0 004 1816135666 
LOK |0 005 20220908053456 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#74F58B464C4B25F5FC5ABBC00772FCC55D14CEC0 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1  |b inherited from superior work 
ORI |a SA-MARC-ixtheoa001.raw